Funding Rounds
Pleco Therapeutics

Pleco Therapeutics Series A (2022, $17M)

Pleco Therapeutics

Pharmaceutical company offering pre-clinical development programs for cancer treatment.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $17.21M

Raised Date: 2022-01-01

Investors